Category: Disease States

Disease States

Quest Diagnostics has launched a new PCR-based diagnostic test for the Oropouche virus, enhancing preparedness for this emerging disease.

ClearNote Health has received UKCA marking for its Avantect Pancreatic Cancer Test, enabling commercial availability in the UK.

Diagnosing lupus remains a major challenge, but emerging biomarkers offer significant promise in improving early and accurate detection.

AMP has published consensus best practice recommendations to standardize HRD testing in clinical laboratories.

Researchers have developed a handheld TB test that accurately detects tuberculosis in HIV-positive individuals using a single drop of blood.

Juniper Genomics has launched publicly to offer a next-generation embryo screening platform that aims to improve IVF outcomes.

A new peer-reviewed study validates Vibrant Sciences’ microarray, enabling fast, accurate, scalable detection of over 17 tickborne pathogens.

University of Tokyo researchers have developed a non-invasive, AI-powered imaging system that tracks platelet activity in real time.

Quanterix Corporation's HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration in South Korea.

Two studies demonstrate how AI models can significantly improve early detection of type 1 diabetes, enabling earlier intervention.

A pilot program using Healthy.io’s FDA-cleared smartphone-powered Minuteful Kidney test significantly improved CKD screening and diagnosis.

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Sepsis is a life-threatening emergency caused by the body's extreme response to infection, requiring rapid diagnosis and treatment.